Cellyan Biotechnology Ltd. engages in providing pharmaceutical cross-border e-commerce supply chain services. The company employs 27 full-time employees The company went IPO on 2025-01-15. The firm mainly provides two services. The supply chain services mainly provide OTC pharmaceutical cross-border e-commerce supply chain services. The procurement and distribution services mainly provide OTC pharmaceutical cross-border procurement and distribution services.
Cellyan Biotechnology Co Ltd의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Cellyan Biotechnology Co Ltd 주요 수익원은 Customized이며, 최신 수익 발표에서 수익은 11,722,295입니다. 지역별로는 Singapore이 Cellyan Biotechnology Co Ltd의 주요 시장이며, 수익은 9,028,520입니다.
Cellyan Biotechnology Co Ltd은 수익성이 있나요?
no, 최신 재무제표에 따르면 Cellyan Biotechnology Co Ltd의 순손실은 $0입니다.